NEW YORK (GenomeWeb) – Investment bank Stifel this week initiated coverage of four life science tools firms operating in the omics market and said that, overall, the space is poised for growth in the coming years as major end markets have stabilized and are improving for the first time in years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.